THOUSAND OAKS, Calif., Amgen today announced the submission of an application to the U.S. Food and Drug Administration (FDA) seeking approval of a single-dosing option for the monthly administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback